|  |  |  |  |  |
| Company | IBL-America | IBL-America | IBL-America | IBL-America | IBL-America |
| Item | Human T-Cadherin(130K) ELISA | Anti-Insulin Antibodies (AIA) RIA Assay | Echinococcus IgG ELISA | Gd-IgA1 (Galactose-deficient IgA1) ELISA | Leptin (High Sensitivity) ELISA Assay |
| Catalog Number | 27364 | KIP0091 | IB79843 | 27600 | E077 |
| Price | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |
| Description | Solid phase sandwich ELISA designed for the determination of T-Cadherin (130k) in human serum and EDTA-plasma. For research use only, not for use in diagnostic procedures. | Radioimmunoassay (RIA) for the determination of human free anti-insulin antibodies (AIA) in serum and plasma. FDA exempt, can be used for in-vitro diagnostics. | Enzyme immunoassay for the determination of IgG class antibodies against Echinococcus in human serum or plasma. 510(k) exempt, can be used for in-vitro diagnostics. | Solid phase sandwich ELISA for the determination of Gd-IgA1 (Galactose-deficient IgA1) in human serum, EDTA-plasma, and urine. For research use only, not for use in diagnostic procedures.
Galactose-deficient IgA1 (Gd-IgA1) has attracted a lot of attention as a critical effector molecule in the Solid phase sandwich ELISA for the determination of Gd-IgA1 (Galactose-deficient IgA1) in human serum, EDTA-plasma, and urine. For research use only, not for use in diagnostic procedures.
Galactose-deficient IgA1 (Gd-IgA1) has attracted a lot of attention as a critical effector molecule in the pathogenesis and progression of IgA nephropathy (IgAN) in recent studies. It has been suggested that several O-link glycans-modified regions exist in the heavy chain hinge region of human IgA1 molecule and Gd-IgA1 circulates in the bloodstream of test samples with the pathological condition of IgAN.... Read More | Inquire |
| Detection Target | Human T-Cadherin(130K) | Anti-Insulin Antibodies (AIA) | Pregnenolone | Metanephrine / Normetanephrine | Human Total Tau |
| Sample Type | Serum, Blood Plasma | Serum, Blood Plasma | Serum | Urine | CSF |
| Method | Enzyme-Linked Immunosorbent Assay (ELISA) | Radio Immuno Assay (RIA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) |
| Detection Range | 0/ 0.03 - 2 ng/mL | 0 to 100% | A cut-off control is used for the interpretation of results. | 1.56 to 100.0 ng/mL | 0.05 to 5.00 ng/mL |
| Sensitivity | 90.91% (95% confidence interval: 58.72% - 99.77%) | Inquire | 0.05 ng/mL | Metanephrine: 13 ng/mL; Normetanephrine: 23 ng/mL. | 4.18 pg/mL |
| Assay Time | 90 min. (37°C) + 30 min. (2-8°C) + 30 min. (RT) = 2 hours total incubation time. | 2 hrs, 30 mins (incubation) | 1 hour, 45 min. total incubation time. | 2 hours (incubation) | 1 hr 45 mins (incubation) |
| Get Quote | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |